INM
InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc. insider trading
Insiders at InMed Pharmaceuticals Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was ADAR1 Capital Management, LLC (10% Owner) buying $70.4K of INM, filed Sep 16, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $118.1K
- Sold
- —
- Insiders
- 1
- Latest trade
- Sep 15, 2026
From SEC filings · last 30 days
Recent INM insider transactions
SEC Form 4 data, Q3 2024 to Q2 2026
INM insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 3 insiders traded INM on the open market: 21 purchases worth $1.1M and 1 sale worth $43. In the last four quarters alone: 21 purchases ($1.1M) and 0 sales, by 2 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | +$1.1M21 buys | — | |
| Q1 2026 | — | — | |
| Q4 2025 | — | — | |
| Q3 2025 | — | — | |
| Q2 2025 | — | — | |
| Q1 2025 | — | — | |
| Q4 2024 | — | — | |
| Q3 2024 | — | −$431 sale |
- Largest purchase
- +$312K of INM by Schneeberger Daniel (10% Owner) on May 19, 2026.
- Largest sale
- −$43 of INM by Mancini Alexandra Diane Janet (Consultant) on Jul 31, 2024.
Open-market transactions through Jun 30, 2026most recent first
Vivo Opportunity, LLC
10% Owner
+$44.9K
Jun 08, 2026
29,518 sh · $1.52
Vivo Opportunity, LLC
10% Owner
+$4.5K
Jun 08, 2026
2,982 sh · $1.52
Vivo Opportunity, LLC
10% Owner
+$78.4K
Jun 05, 2026
49,966 sh · $1.57
Vivo Opportunity, LLC
10% Owner
+$7.9K
Jun 05, 2026
5,045 sh · $1.57
Vivo Opportunity, LLC
10% Owner
+$9.6K
Jun 04, 2026
6,125 sh · $1.57
Vivo Opportunity, LLC
10% Owner
+$970
Jun 04, 2026
618 sh · $1.57
Vivo Opportunity, LLC
10% Owner
+$11K
Jun 03, 2026
7,069 sh · $1.55
Vivo Opportunity, LLC
10% Owner
+$1.1K
Jun 03, 2026
714 sh · $1.55
Vivo Opportunity, LLC
10% Owner
+$31.5K
Jun 02, 2026
20,753 sh · $1.52
Vivo Opportunity, LLC
10% Owner
+$3.2K
Jun 02, 2026
2,095 sh · $1.52
Vivo Opportunity, LLC
10% Owner
+$23K
Jun 01, 2026
14,838 sh · $1.55
Vivo Opportunity, LLC
10% Owner
+$2.3K
Jun 01, 2026
1,498 sh · $1.55
Vivo Opportunity, LLC
10% Owner
+$25.4K
May 29, 2026
16,164 sh · $1.57
Vivo Opportunity, LLC
10% Owner
+$2.6K
May 29, 2026
1,632 sh · $1.57
Vivo Opportunity, LLC
10% Owner
+$52.2K
May 21, 2026
30,882 sh · $1.69
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Jun 08, 2026 | Vivo Opportunity, LLC10% Owner | 29,518 | $1.52 | +$44.9K |
| Jun 08, 2026 | Vivo Opportunity, LLC10% Owner | 2,982 | $1.52 | +$4.5K |
| Jun 05, 2026 | Vivo Opportunity, LLC10% Owner | 49,966 | $1.57 | +$78.4K |
| Jun 05, 2026 | Vivo Opportunity, LLC10% Owner | 5,045 | $1.57 | +$7.9K |
| Jun 04, 2026 | Vivo Opportunity, LLC10% Owner | 6,125 | $1.57 | +$9.6K |
| Jun 04, 2026 | Vivo Opportunity, LLC10% Owner | 618 | $1.57 | +$970 |
| Jun 03, 2026 | Vivo Opportunity, LLC10% Owner | 7,069 | $1.55 | +$11K |
| Jun 03, 2026 | Vivo Opportunity, LLC10% Owner | 714 | $1.55 | +$1.1K |
| Jun 02, 2026 | Vivo Opportunity, LLC10% Owner | 20,753 | $1.52 | +$31.5K |
| Jun 02, 2026 | Vivo Opportunity, LLC10% Owner | 2,095 | $1.52 | +$3.2K |
| Jun 01, 2026 | Vivo Opportunity, LLC10% Owner | 14,838 | $1.55 | +$23K |
| Jun 01, 2026 | Vivo Opportunity, LLC10% Owner | 1,498 | $1.55 | +$2.3K |
| May 29, 2026 | Vivo Opportunity, LLC10% Owner | 16,164 | $1.57 | +$25.4K |
| May 29, 2026 | Vivo Opportunity, LLC10% Owner | 1,632 | $1.57 | +$2.6K |
| May 21, 2026 | Vivo Opportunity, LLC10% Owner | 30,882 | $1.69 | +$52.2K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check INM — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
InMed Pharmaceuticals Inc. is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are INM insiders buying or selling?
- Between Sep 16, 2026 and Sep 15, 2026, 1 InMed Pharmaceuticals Inc. insider made 3 open-market purchases worth $118.1K and no sales, a net purchase of $118.1K.
- How much INM stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 3 InMed Pharmaceuticals Inc. insiders made 21 open-market purchases worth $1.1M and 1 sale worth $43. In the four quarters to Jun 30, 2026: 21 purchases ($1.1M) and no sales. The largest purchase was Schneeberger Daniel buying $312K on May 19, 2026. The largest sale was Mancini Alexandra Diane Janet selling $43 on Jul 31, 2024.
- What was the largest recent INM insider trade?
- ADAR1 Capital Management, LLC (10% Owner) bought $70.4K of INM stock on Sep 15, 2026 at about $1.30 a share.
- When did an insider last buy INM shares?
- The most recent open-market purchase on file is ADAR1 Capital Management, LLC (10% Owner) buying $10.8K on Sep 16, 2026. The largest purchase in the period was $70.4K by ADAR1 Capital Management, LLC.
- Where does INM insider trading data come from?
- From the Form 4 filings InMed Pharmaceuticals Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.